This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.innocentive.com/challenges/alternative-scalable-synthetic-routes-for-phase-ii-ready-small-molecule-cost-efficient-manufacture-for-clinical-and-commercial-supply/